SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD DEC 05
MCX SILVER DEC 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD DEC 05
MCX SILVER DEC 05
MCX CRUDEOIL NOV 16
MCX NATURALGAS OCT 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

Closing Bell: Nifty, Sensex pare losses; financials, metals drag

Asian stocks edge higher, Aussie in demand on recovery signs

Oil guzzler India says OPEC+ decision to hit economic recovery

Rupee slumps 16 paise to 72.99 against US dollar in early trade

Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock deal

Updated : January 18, 2021 09:24 AM IST

Diagnostic chain Metropolis Healthcare on Sunday said it will acquire Dr Ganesan’s Hitech Diagnostic Centre Pvt Ltd in a cash and stock combination deal, to strengthen its leadership position in southern India. The company’s board has approved the acquisition partly by way of cash consideration of Rs 511 crore and partly by issuance of up to 4,95,000 equity shares of a face value of Rs 2 each on a preferential basis, to the promoter group of Hitech, MetropolisHealthcare said in a regulatory filing.

”The cash consideration will be funded through internal accruals and debt of up to Rs 300 crore,” it added. S P Ganesan, its promoter and founder, will be part of the leadership team for the next few years to enable a smooth transition and integration with Metropolis, the filing said.

Metropolis will get access to 31 laboratories, including three NABL- and ICMR-accredited laboratories and 68 collection centres of Hitech. The acquisition is expected to be completed within three months, it added. Metropolis Healthcare Managing Director Ameera Shah said, ”In line with the strategy to grow, gain market share and increase B2C (business-to-consumer) revenues in focus cities, we are acquiring Hitech Diagnostic Centre which will strengthen our leadership position in the South India market.”

The objective of Metropolis with the acquisition is to increase its market share in focus cities of Chennai and Bengaluru and become leaders in some tier-2 towns in southern India, she added.

”We will capture the mid-segment of the market, increase our B2C revenue contribution and leverage scale benefits through cost synergies,” Shah said. Dr Ganesan’s Hitech Diagnostic Centre Pvt Ltd Promoter S P Ganesan said Metropolis is the right brand to carry forward the legacy of Hitech.

”We shall ensure a smooth integration of Hitech’s business with Metropolis to increase the value for the combined entity through cost synergies and create a much stronger consumer brand in South India.”

The acquisition will allow Metropolis to increase its B2C business in focus cities of Chennai and Bengaluru. It will benefit through optimisation of operational costs in the areas of procurement, supply chain, administration and support resource, laboratory network and back-office infrastructure, Metropolis Healthcare said.

It will further allow Metropolis brand to make deeper inroads in different customer segments across key markets in South India, it added.

Published : January 18, 2021 08:59 AM IST

You May Also Like

DHFL auditor Grant Thornton finds another fraud of Rs 1,424 crore

DHFL auditor Grant Thornton finds another fraud of Rs 1,424 crore

Govt mandates dual air bags in new models from April 1

Govt mandates dual air bags in new models from April 1

Union Budget to be presented on Feb 1: Report

Union Budget to be presented on Feb 1: Report

Trending on CNBC-TV18

Live TV

recommended for you